Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on September 14, 2025
Eric Malley Launches Groundbreaking Book, Spherical Philosophy™, Bridging Recovery and Business Innovation
A universal framework for resilience, empathy, and multidimensional growth transforming personal journeys and organizational leadership NEW YORK CITY, NY, UNITED STATES, September 14, 2025 /EINPresswire.com/ -- Eric Malley Announces Launch of Spherical …
LogsDay Releases Science-Backed Guide on Safe Supplements for Child Growth and Development
LogsDay’s new guide highlights safe, science-backed supplements to support child growth, immunity, brain health, and overall development PUNE, MAHARASHTRA, INDIA, September 14, 2025 /EINPresswire.com/ -- A newly published guide on LogsDay, “𝐒𝐜𝐢𝐞𝐧𝐜𝐞- …
LogsDay Explores How the Mediterranean Diet Can Work for Non-Mediterranean Populations
LogsDay shows how the Mediterranean diet can be adapted globally with local foods, improving heart health, gut health, and overall wellness. PUNE, MAHARASHTRA, INDIA, September 14, 2025 /EINPresswire.com/ -- LogsDay, a leading lifestyle and wellness …
Dr. Manish Gupta Joins ReliefNow® Laser Methods as Chief Medical Officer—Advancing Class IV Laser Use in Orthopedics
MIAMI, FL, UNITED STATES, September 14, 2025 /EINPresswire.com/ -- ReliefNow® Laser Methods has announced the appointment of Dr. Manish Gupta, MD, FAAOS, as its new Chief Medical Officer. Dr. Gupta, a board-certified orthopedic surgeon and fellowship- …
AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
VALENCIA, Calif., Sept. 14, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical”, or the “Company”), a leading therapeutic acute wound care company, today announced it has received the CE Mark under the European Union …
Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced …